Biogen is aiming to expand across the West Coast and is planning to open a hub in South San Francisco. Good news for Bay Area ...

Biogen will open a West Coast hub in South San Francisco after acquiring a Peninsula drugmaker. HI-Bio's operations have ...

As an independent biotechnology company, Biogen (Cambridge, MA) has led innovation in treatment and outcomes assessment in MS for >25 years and continues to have an enduring commitment to elevate ...

Biogen in 2019 exercised a license option with Ionis Pharmaceuticals and obtained an exclusive royalty-bearing license to develop and commercialize BIIB080. Cambridge, Mass., biotechnology company ...

Biogen, Inc. is a biopharmaceutical company ... and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

The company intends to be the building’s sole corporate tenant, allowing it to “optimize its real estate footprint in Cambridge” and “create a purpose-built innovation hub.” Biogen’s ...

With a market cap of $17.4 billion, Biogen Inc. (BIIB ... Ahead of this event, analysts expect the Cambridge, Massachusetts-based company to report a profit of $3.34 per share, down nearly ...

We are grateful to Chris Viehbacher, president and chief executive officer of Biogen, for his keen vision of the future and his ongoing commitment to Cambridge and Kendall Square.” “Massachusetts is ...

Ivana Rubino works at Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States. Bruce Albala works at Eisai, Inc., 100 Tice Boulevard, Woodcliff Lake ...